CD19 and acute lymphoblastic leukemia: In one such study, investigators used CD19-tPSMA CAR T cells tagged with 18-fluorinated-DCFPyL against an acute lymphoblastic leukemia (ALL) mouse model to characterize CAR T durability and persistence (19).